NZ575030A - Histone deacetylase inhibitors with combined activity on class-I and class-IIb histone deacetylases in combination with proteasome inhibitors - Google Patents
Histone deacetylase inhibitors with combined activity on class-I and class-IIb histone deacetylases in combination with proteasome inhibitorsInfo
- Publication number
- NZ575030A NZ575030A NZ575030A NZ57503007A NZ575030A NZ 575030 A NZ575030 A NZ 575030A NZ 575030 A NZ575030 A NZ 575030A NZ 57503007 A NZ57503007 A NZ 57503007A NZ 575030 A NZ575030 A NZ 575030A
- Authority
- NZ
- New Zealand
- Prior art keywords
- leukemia
- combination
- drug resistant
- acute
- inhibitor
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06120726 | 2006-09-15 | ||
| US91589507P | 2007-05-03 | 2007-05-03 | |
| PCT/EP2007/059518 WO2008031817A2 (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ575030A true NZ575030A (en) | 2012-07-27 |
Family
ID=41040414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ575030A NZ575030A (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-I and class-IIb histone deacetylases in combination with proteasome inhibitors |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN101516374B (zh) |
| BR (1) | BRPI0716992A2 (zh) |
| DK (1) | DK2066327T3 (zh) |
| ES (1) | ES2399670T3 (zh) |
| ME (1) | ME01514B (zh) |
| NZ (1) | NZ575030A (zh) |
| PT (1) | PT2066327E (zh) |
| RS (1) | RS52638B (zh) |
| SG (1) | SG177219A1 (zh) |
| SI (1) | SI2066327T1 (zh) |
| UA (1) | UA97249C2 (zh) |
| ZA (1) | ZA200901818B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8957066B2 (en) * | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| CN107095871A (zh) * | 2016-02-22 | 2017-08-29 | 中国科学院上海巴斯德研究所 | Quisinostat，一种新型的高效抗疟药物 |
| KR20190030693A (ko) * | 2016-07-20 | 2019-03-22 | 더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 | 히스톤 아세틸트랜스퍼라제 활성화제 및 이의 조성물 및 용도 |
| CN114409638B (zh) * | 2022-02-09 | 2023-02-14 | 深圳大学 | 组蛋白去乙酰化酶8选择性降解剂、制备方法及其在抗肿瘤活性中的应用 |
| CN115028678A (zh) * | 2022-07-08 | 2022-09-09 | 杭州医学院 | 基于vhl配体诱导bcr-abl蛋白降解的双功能分子及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006010750A1 (en) * | 2004-07-28 | 2006-02-02 | Janssen Pharmaceutica N.V. | Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
-
2007
- 2007-09-11 PT PT78033974T patent/PT2066327E/pt unknown
- 2007-09-11 NZ NZ575030A patent/NZ575030A/en unknown
- 2007-09-11 SG SG2011092863A patent/SG177219A1/en unknown
- 2007-09-11 UA UAA200900388A patent/UA97249C2/ru unknown
- 2007-09-11 ME MEP-2013-15A patent/ME01514B/me unknown
- 2007-09-11 DK DK07803397.4T patent/DK2066327T3/da active
- 2007-09-11 BR BRPI0716992-2A2A patent/BRPI0716992A2/pt not_active Application Discontinuation
- 2007-09-11 SI SI200731143T patent/SI2066327T1/sl unknown
- 2007-09-11 ES ES07803397T patent/ES2399670T3/es active Active
- 2007-09-11 RS RS20130038A patent/RS52638B/en unknown
- 2007-09-11 CN CN200780034143.2A patent/CN101516374B/zh active Active
-
2009
- 2009-03-13 ZA ZA200901818A patent/ZA200901818B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0716992A2 (pt) | 2013-09-17 |
| ZA200901818B (en) | 2010-05-26 |
| PT2066327E (pt) | 2013-02-06 |
| ME01514B (me) | 2014-04-20 |
| SI2066327T1 (sl) | 2013-04-30 |
| SG177219A1 (en) | 2012-01-30 |
| CN101516374A (zh) | 2009-08-26 |
| UA97249C2 (ru) | 2012-01-25 |
| CN101516374B (zh) | 2013-04-24 |
| RS52638B (en) | 2013-06-28 |
| DK2066327T3 (da) | 2013-02-11 |
| ES2399670T3 (es) | 2013-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090270419A1 (en) | Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors | |
| CA2659070C (en) | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors | |
| ES2814290T3 (es) | Inhibidores de IDH1 mutante | |
| EP3842429B1 (en) | Heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer | |
| US20230372496A1 (en) | Tricyclic heterobifunctional compounds for degradation of targeted proteins | |
| ES2322950T3 (es) | Derivados de aminocarbonilo como nuevos inhibidores de histona-desacetilasa. | |
| CA3118330A1 (en) | Inhibitors of cyclin-dependent kinase 7 (cdk7) | |
| EP3265073B1 (en) | Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof | |
| NZ575030A (en) | Histone deacetylase inhibitors with combined activity on class-I and class-IIb histone deacetylases in combination with proteasome inhibitors | |
| US20210347761A1 (en) | Usp7 inhibition | |
| WO2013021032A1 (en) | Histone deacetylase inhibitors in combination with proteasome inhibitors and dexamethasone | |
| Zhao et al. | Discovery of cysteine-targeting covalent histone methyltransferase inhibitors | |
| AU2016277929B2 (en) | Combination therapy using belinostat and pralatrexate to treat lymphoma | |
| Srinivasan et al. | Allosteric Inhibitors of Hsp70: Drugging the second chaperone of tumorigenesis | |
| CA3224123A1 (en) | Small molecule inhibition of deubiquitinating enzyme josephin domain containing 1 (josd1) as a targeted therapy for leukemias with mutant janus kinase 2 (jak2) | |
| JP2021167301A (ja) | Ｃｄｋ２阻害剤に対する腫瘍適応を抑制するためのｃｄｋ４／６およびｃｄｋ２阻害剤による同時処置 | |
| CN116348105A (zh) | 芳基吡咯衍生物的药用盐 | |
| Koay | Design, synthesis and evaluation of C-terminal heat shock protein 90 (Hsp90) modulators as anticancer agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 11 SEP 2017 BY CPA GLOBAL Effective date: 20140731 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 11 SEP 2020 BY CPA GLOBAL Effective date: 20140906 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 SEP 2021 BY CPA GLOBAL Effective date: 20200730 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 SEP 2022 BY CPA GLOBAL Effective date: 20210729 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 SEP 2023 BY CPA GLOBAL Effective date: 20220729 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 SEP 2024 BY CPA GLOBAL Effective date: 20230803 |